Topography-guided PRK followed by corneal collagen cross-linking yielded a significantly greater improvement in vision than cross-linking alone in eyes with progressive keratoconus, a study found.Both procedures yielded similarly stable postoperative o…
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2…
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first-in-class drug therapies for the eye, announces that Richard J. Croarkin is joining its Board of Directors.
CHANTILLY, Va.–(BUSINESS WIRE)–Notal Vision, Inc. is pleased to announce that the ForeseeHome AMD Monitoring Program is now available for eligible Medicare patients across the U.S. ForeseeHome is available by prescription for patients with Dry Age-related Macular Degeneration (AMD) at high risk for developing Wet AMD. The clinical utility for ForeseeHome was established in the Home Monitoring of the Eye (HOME) Study, part of a National Eye Institute-sponsored study, where over 1500 patients w
LEXINGTON, Mass.–(BUSINESS WIRE)–David P. Southwell, President and CEO of Inotek, will present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7th, 2016 at 2:00 ET at the Boston Marriott Copley Place Hotel
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2015. “2015 was highlighted by the filing of our NUPLAZID™ (pimavanserin) New Drug Application for Parkinson’s disease psychosis and the designation of Priority Review b